People with localised, low-to-intermediate-risk prostate cancer could benefit from Stereotactic Body Radiation Therapy (SBRT), a highly targeted form of radiotherapy, which research suggests may be ...

The Institute of Cancer Research, London, works closely with trusts, foundations and charity partners who play an important part in enabling our state-of-the-art research. We recently marked a ...

Professor Paul Workman OBE has been awarded the Enrst W. Bertner Memorial Award by The University of Texas MD Anderson Cancer Center, for his distinguished contributions to cancer research. The award, ...

Patients with the most aggressive forms of the blood cancer multiple myeloma can live significantly longer when their treatment is tailored to their disease, according to new long‑term results from a ...

Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in ...

Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute ...

The National Institute for Health and Care Excellence (NICE) criteria used to decide who should be referred by GPs for further breast cancer risk assessment and specialist care misses up to 95 per ...

The Government has today published the National Cancer Plan, setting out a 10-year strategy to improve cancer outcomes in England through new targets and measures to accelerate diagnosis and treatment ...

In this feature, cancer scientists and animal research experts across The Institute of Cancer Research, London, discuss why breakthroughs gained by studying whole-body systems in animals are essential ...

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...

Cancer doesn’t just impact a patient, it has repercussions for everyone around them. Friends and family of those affected by the disease process feelings in many different ways, but some channel their ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...